TribLIVE

| Home


Weather Forecast
 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

 

 
 


Show commenting policy

Most-Read Stories

  1. Harrison shines again as Pirates clip Reds, 2-1
  2. Secret judicial ruling blocks release of sexually explicit emails
  3. Steelers claim former Cowboys cornerback Webb
  4. Franklin Regional security guard fighting to get job back
  5. High school roundup: Greensburg Salem shocks Gateway in opener
  6. Veteran Keisel settles into role with Steelers
  7. Pitt’s obscure opener still matters
  8. Pirates notebook: Lambo recalled to bolster bench
  9. Gas drilling company withdraws application for forced pooling in Western Pennsylvania
  10. DEP releases details of cases of drinking well contamination from drilling
  11. Trueman sparks North Allegheny’s 14-0 victory over Seneca Valley
Subscribe today! Click here for our subscription offers.